| abstract |
The present invention relates to metabolites of (thio) -carbamoyl-cyclohexane derivatives, in particular metabolites of trans-4- {2- [4- (2,3-dichlorophenyl) -piperazin-1-yl] -ethyl} -n, n-dimethylcarbamoyl-cyclohexylamine) and their pharmaceutically acceptable salts, pharmaceutical compositions containing them and their use for the treatment and / or prevention of a condition requiring modulation of dopamine receptors. |